/BIOS.BR
BIOS.BR Stock - BioSenic S.A.
Healthcare|BiotechnologyBRU
$0.00-4.35%
$0.00 (-4.35%) • Dec 23
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.38
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BIOS.BR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-2.43
52W High$0.01
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | $543,000 | $296,000 | $312,000 | $1.00M |
| Gross Profit | $-196,000 | $543,000 | $296,000 | $987,000 | $1.00M |
| Gross Margin | N/A | 100.0% | 100.0% | 316.3% | 100.0% |
| Operating Income | $-8,272,000 | $-7,040,000 | $-2,318,000 | $-1,189,000 | $-15,017,000 |
| Net Income | $-4,768,000 | $-28,778,000 | $-2,041,000 | $-984,000 | $-11,940,000 |
| Net Margin | N/A | -5299.8% | -689.5% | -315.4% | -1194.0% |
| EPS | $-0.02 | $-0.21 | $-0.02 | $-0.05 | $-1.02 |
Company Overview
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BIOS.BRBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.00
Q3 2024
EPS Surprise History
Q2 21
No data
Q4 21
No data
Q2 22
No data
Q2 22
No data
Q2 23
No data
Q4 23
No data
Q2 24
No data
Q3 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Jun 2, 2025 | — | — | — | — |
Q2 2025 | May 29, 2025 | — | — | — | — |
Q3 2024 | Sep 30, 2024 | — | $0.00 | — | — |
Q2 2024 | Jun 7, 2024 | — | $-0.05 | — | — |
Q4 2023 | Oct 26, 2023 | — | $-0.17 | — | — |
Q2 2023 | May 22, 2023 | — | $-0.01 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.15 | — | — |
Q2 2022 | Apr 29, 2022 | — | $-0.40 | — | — |
Q4 2021 | Oct 27, 2021 | — | $-0.37 | — | — |
Q2 2021 | Apr 29, 2021 | — | $-0.14 | — | — |
Q4 2020 | Oct 30, 2020 | — | $-0.88 | — | — |
Q2 2020 | Apr 29, 2020 | — | $-0.46 | — | — |
Q4 2019 | Nov 6, 2019 | — | $-0.64 | — | — |
Q2 2019 | May 7, 2019 | — | $-0.70 | — | — |
Q4 2018 | Nov 7, 2018 | — | $-1.03 | — | — |
Q2 2018 | Apr 25, 2018 | — | $-0.93 | — | — |
Q4 2017 | Nov 9, 2017 | — | $-0.93 | — | — |
Q2 2017 | May 11, 2017 | — | $-0.95 | — | — |
Q4 2016 | Nov 2, 2016 | — | $-0.95 | — | — |
Q2 2016 | May 10, 2016 | — | $-1.07 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BIOS.BR
What is BIOS.BR's current stock price?
BioSenic S.A. (BIOS.BR) is currently trading at $0.00 per share. The stock has moved -4.35% today.
What is the analyst price target for BIOS.BR?
No analyst price targets are currently available for this stock.
What sector is BioSenic S.A. in?
BioSenic S.A. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the BRU exchange.
What is BIOS.BR's market cap?
BioSenic S.A. has a market capitalization of $0.00 billion, making it a small-cap company.
Does BIOS.BR pay dividends?
No, BioSenic S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCYAD.BR
Celyad Oncology S.A.
$0.18
Mkt Cap: $0.0B
GNRO.PA
GeNeuro S.A.
$0.03
Mkt Cap: $0.0B
OXUR.BR
Oxurion N.V.
$0.01
Mkt Cap: $0.0B
VVY.AS
Vivoryon Therapeutics N.V.
$1.48
Mkt Cap: $0.0B
Explore stocks similar to BIOS.BR for comparison